Bristol Myers Squibb, 2seventy bio shares fall as FDA delays action on cancer treatment
November 20, 2023 at 08:35 AM EST
Shares of Bristol Myers Squibb, 2seventy bio fell early Monday as FDA said it would miss a regulatory action date on a cancer treatment
